Shire Wins Dismissal Of Adderall Antitrust Suit

Law360, Washington (March 6, 2013, 4:42 PM EST) -- A New York federal judge on Wednesday tossed a drug wholesaler's putative antitrust class action against Shire LLC for allegedly stifling generic competition for its blockbuster ADHD treatment Adderall XR, saying the company's behavior within its patent licensing agreements didn't create an antitrust issue.

Louisiana Wholesale Drug Co. Inc. had claimed Shire artificially inflated prices by holding back some of its Adderall XR supply from patent licensees Teva Pharmaceutical Industries Ltd. and Impax Laboratories Inc. But U.S. District Judge Victor Marrero said the wholesaler and others...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.